Saudin F
Service de Réanimation, Hôtel-Dieu, Lyon, France.
Pediatrie. 1987;42(5):339-49.
Somatostatin has several effects on the secretions of the gastrointestinal tract. The assessment of therapeutic use is based on literature review. The rebound and escape phenomena are the main problems in the clinical use of somatostatin and their prevention is perhaps possible by the prescription of a long-acting analogue in an intermittent mode of administration.